Virology Market By Product Type (DNA Viruses, RNA Viruses, Prions Diagnostic Test, and Other Viral Tests), By Viral Infection Controlling Method (Immunoprophylaxis, Active Prophylaxis, Passive Prophylaxis, Antiviral Chemotherapy (Veridical Agents, Antiviral Agents, and Immunomodulators), and Interferons), By Application (Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Urinary Tract Infection, Eye Infections, Sexually Transmitted Diseases, and Perinatal Infections), By End-User (Hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, and Pharmacies), and By Region - Trends, Analysis and Forecast till 2030

The virology market accounted for USD 1.92 Billion in 2020 and is estimated to be USD 4.89 Billion by 2030 and is anticipated to register a CAGR of 9.9%.

Virology is study of viruses including submicroscopic, parasitic particles of genetic material contained in a protein coat, and virus-like agents. Virology is concentrated on distribution, biochemistry, physiology, ecology, evolution, molecular biology, and clinical aspects of viruses. Viruses are responsible for controlled or developed diseases. Viruses have beneficial properties that can be used in gene therapy or vaccinology. According to data published by Institute of Human Virology (IHV), IHV has a unique HIV/AIDS vaccine which is designed to neutralize many different strains of HIV found across the globe. Virology starts when there was no procedure for propagating or visualizing viruses or specific laboratory tests for viral infection.

The methods for separating viral nucleic acids (RNA & DNA) and proteins, which are now the mainstay of virology, did not exist. Thousand of different viruses are now known about virologists often specialize in either the viruses that infect plants, or bacteria and other microorganisms, or animals. Virologists are scientists who examine, study, and explore viruses and viral diseases. Moreover, they are responsible for studying the growth, development, characteristics, and structure of various viruses.

Prevalence of viral diseases across the globe is driving the virology market. In addition, increasing public awareness programs across the globe on Flu, Zika virus, STDs, AIDS, and Ebola virus is also expected to propel the target market. Furthermore, rising demand for R&D application from healthcare sector for cure and prevention of diseases is expected to fuel the virology market. Moreover, various treatments and diagnostic processes utilize virology applications is augmenting the target market. Recent, outbreak of corona virus had a adverse effect on health worldwide is the another factor which boost the growth of the target market.

However, maintaining the quality and safety standards of viral a controlling therapy may restrain the virology market.

The virology market is segmented based on product type, viral infection controlling method, application, end-user, and region.

On the basis of product type, the target market is segmented into DNA viruses, RNA viruses, prions diagnostic test, and other viral tests. On the basis of viral infection controlling method, the virology market is categorized into the immunoprophylaxis, active prophylaxis, passive prophylaxis, antiviral chemotherapy, and interferons. On the basis of application, the target market is divided into skin and soft tissue infections, respiratory tract infections, GI tract infections, urinary tract infection, eye infections, sexually transmitted diseases, and perinatal infections. On the basis of end-user, the virology market is classified into hospitals, clinics, laboratories, diagnostic centers, blood banks, and pharmacies.

Regional Insights:

The virology market accounted for US$ 1.92 billion in 2020 and is estimated to be US$ 4.89 billion by 2030 and is anticipated to register a CAGR of 9.9%. On region the virology market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America virology market is expected to account for largest share in terms of revenue in the virology market over the forecast period. This is attributed to technological advancements such as the increasing rapid and portable diagnostics in countries such as U.S. of the region. Asia Pacific virology market is expected to account for second-highest share in terms of revenue in the virology market in the near future. This is owing to growing healthcare infrastructure, facilitated to diagnostics, and affordability of diagnostic tests for viral diseases in countries of the region.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at , regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the virology market report based on product type, viral infection controlling method, application, end-user, and region.

Virology Market, By Region:

• North America
  • Middle East & Africa
    • GCC
    • Israel
    • South Africa
    • Rest of Middle East & Africa
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • U.S.
  • Canada

The key players operating in the virology market includes GlaxoSmithKline plc, Abbott Laboratories, Boehringer Ingelheim Corporation, Merck KGaA, Novartis International AG, Siemens AG, Johnson & Johnson, AstraZeneca AB, Roche Holding AG, and Abivax SA. Technological advancements in the product as well as in manufacturing process, product launches, and strategic partnerships are some trends witnessed in the virology market.

• GlaxoSmithKline plc.
• Abbott Laboratories
• Boehringer Ingelheim Corporation
• Merck KGaA
• Novartis AG
• AbbVie Inc.
• Johnson & Johnson
• AstraZeneca plc
• Fritz Hoffmann-La Roche
• Abivax SA